Navigation Links
Optimer Pharmaceuticals and Cubist Pharmaceuticals Announce Collaboration to Co-Promote DIFICID™ (Fidaxomicin) for Clostridium difficile Infection in the United States
Date:4/6/2011

acteria, including MRSA.

"Cubist has a proven track record and well established relations with all stakeholders involved in the antibiotics space.  We believe this collaboration will maximize the impact of and de-risk DIFICID's U.S. commercial launch, assuming approval," said Pedro Lichtinger, President and CEO of Optimer.  "Optimer plans to hire 100 sales representatives to target the 1,100 hospitals, which comprise about 70% of U.S. hospital CDI cases.  We also believe this collaboration with Cubist will allow us to accelerate formulary adoption, expand our market reach and penetration to up to 2,000 hospitals, comprising over 90% of U.S. hospital CDI cases, and commit resources to long-term care facilities that comprise approximately one-third of all CDI cases.  In addition, this provides the opportunity to capture the undiagnosed CDI market segment which some estimate to be as many as three million cases per year."

Cubist's President and CEO Michael Bonney said, "We believe that the strengths of Cubist's seasoned sales force, medical affairs team and our experience in the hospital will add tremendous value to Optimer's launch strategy and execution. We look forward to working with Optimer to introduce a much needed therapy for seriously ill patients suffering from CDAD."

The agreement expires two years from the first commercial sale of DIFICID.  The agreement can be renewed for additional terms upon agreement of the parties and can be terminated early by either party in certain defined situations. Optimer will be responsible for the manufacturing and distribution of DIFICID in the United States and for recording product revenue.  Optimer will be responsible for obtaining FDA approval, and will retain ownership of the New Drug Application.  For its efforts under the co-promotion agreement, including providing specified levels of resources and activities, Cubist will receive quarterly service fees of $3.75 mi
'/>"/>

SOURCE Optimer Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Optimer Announces that the U.S. Food and Drug Administrations Anti-Infective Drugs Advisory Committee Voted Unanimously to Recommend Approval of Novel Antibiotic Dificid™ for Treatment of Patients with Clostridium difficile infection (CDI)
2. Trading Halted Today in Optimer Pharmaceuticals Stock
3. Optimer Pharmaceuticals Announces Presentation at SHEA of Data Highlighting the Burden of Clostridium difficile Infection (CDI) in Hospital Patients
4. Optimer Pharmaceuticals Announces Presentation at Upcoming SHEA Annual Meeting Regarding Hospital CDI Patients at Risk of Recurrence and Mortality
5. Optimer Pharmaceuticals Announces Issuance of Key Patent Covering Fidaxomicin Methods of Use as a Treatment of Clostridium difficile infection
6. Optimer Pharmaceuticals Reports Fourth Quarter and Full Year 2010 Financial Results
7. Optimer Pharmaceuticals to Host Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2010 Financial Results
8. Optimer Pharmaceuticals to Present at March 2011 Investor Conferences
9. Optimer Pharmaceuticals, Inc. Prices Public Offering of Common Stock
10. Optimer Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock
11. Optimer Pharmaceuticals and Astellas Announce Collaboration to Commercialize Fidaxomicin for Clostridium difficile infection (CDI) in Europe and Certain Other Countries in Middle East, Africa and CIS
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... March 2, 2015 Edison ... announces the initiation of full coverage of Abzena  ... by Edison,s pharma & biotech analysts Christian ... include: Abzena offers a range of ... safer and more effective biological products. Antitope (immunogenicity ...
(Date:3/2/2015)... 2, 2015  Tandem Diabetes Care®, Inc. (NASDAQ: ... of the t:slim® and t:flex™ Insulin Pumps, today announced ... of common stock have exercised their option to purchase ... a price to the public of $11.50 per share. ... expected to be $64.8 million, after deducting underwriting discounts ...
(Date:3/2/2015)... 2, 2015 For the past 15 years, there has ... in the U.S. alone (U.S. Census Bureau 2012). Of course, not ... benders BUT there are quite a few where the car occupants ... can obstruct the seatbelt release button or occupant injury. ... serious accidents in their lifetime but may still be "lucky" enough ...
Breaking Medicine Technology:Edison Initiates Coverage on Abzena 2Tandem Diabetes Care Announces Exercise of Option to Purchase Additional Shares in Underwritten Public Offering of Common Stock 2Tandem Diabetes Care Announces Exercise of Option to Purchase Additional Shares in Underwritten Public Offering of Common Stock 3New SuperVizor, an Automobile Escape Tool, Ensures the Safety of Drivers and Passengers on the Road 2
(Date:3/2/2015)... (PRWEB) March 02, 2015 In light ... of anticoagulant Xarelto (rivaroxaban) tablets, Ford & ... may be helpful for future users, but may come ... injuries from taking the drug. The FDA has now ... under Adverse Reactions on Xarelto's label. The term “cytolytic ...
(Date:3/2/2015)... March 02, 2015 ProvidaStaff ... for its educational healthcare division to EDU Healthcare ... healthcare services to school systems and students nationwide. , ... to school districts throughout the country,” said Angela M. ... be a better organization and the introduction of EDU ...
(Date:3/1/2015)... To help healthcare organizations ... practices compliantly and profitably, MDreferralPRO and Vericle ... The interoperability between a strategic referral management ... management system is necessary for a healthcare ... referral management and development solution relies on ...
(Date:3/1/2015)... 2015 Women’s Excellence now offers ... (OAB) symptoms, such as a strong need to urinate with ... medication (anticholinergic) does not work well enough or cannot be ... another approach to targeting the source of OAB, the bladder ... and bladder muscle, blocking the signals that trigger OAB. ...
(Date:3/1/2015)... March 01, 2015 A federal ... http://www.consumerinjurylawyers.com/wright-profemur-hip-replacement ) scheduled to go to trial in ... a witness to provide testimony regarding the role ... of the Profemur device, Bernstein Liebhard LLP comments. ... Court, Northern District of Iowa on February 25th, ...
Breaking Medicine News(10 mins):Health News:Ford & Associates Nationwide Legal Services, A.P.C., Comments on Xarelto Lawsuits Upon FDA Revisions 2Health News:Ford & Associates Nationwide Legal Services, A.P.C., Comments on Xarelto Lawsuits Upon FDA Revisions 3Health News:Ford & Associates Nationwide Legal Services, A.P.C., Comments on Xarelto Lawsuits Upon FDA Revisions 4Health News:ProvidaStaff Announces New Name Change to EDU Healthcare for Its Educational Healthcare Division 2Health News:ProvidaStaff Announces New Name Change to EDU Healthcare for Its Educational Healthcare Division 3Health News:Power Up Physician and Patient Referral Management While Qualifying for ARRA Incentives 2Health News:Power Up Physician and Patient Referral Management While Qualifying for ARRA Incentives 3Health News:Power Up Physician and Patient Referral Management While Qualifying for ARRA Incentives 4Health News:Women's Excellence Now Offers BOTOX For Overactive Bladder Treatment 2Health News:Wright Profemur Hip Lawyers at Bernstein Liebhard LLP Comment on Court’s Decision Regarding Testimony Pertaining to Prototype for Profemur Hip Replacement 2Health News:Wright Profemur Hip Lawyers at Bernstein Liebhard LLP Comment on Court’s Decision Regarding Testimony Pertaining to Prototype for Profemur Hip Replacement 3
... may help reduce unnecessary surgeries in women of reproductive ... study appearing in the February issue of the journal ... of preoperative CT over the past decade, along with ... in negative appendectomies among women 45 years and younger," ...
... WASHINGTON , Jan. 25 Detroit -area ... in a Detroit -area home health care fraud scheme, announced ... U.S. Attorney for the Eastern District of Michigan Barbara L. McQuade; ... Field Office; and Special Agent in Charge Lamont Pugh III of ...
... , , "Was John Brown,s raid on Harpers ... a hero or a villain?" Randall Terry , WICHITA, ... by Randall Terry , Director, Operation Rescue Insurrecta Nex. , Statement ... or condemn Scott Roeder,s actions. That decision will soon rest ...
... "America,s health care problems did not change when the ... need Congress to act on Health Care Reform now", insists Dr. ... focus on the economy and jobs is necessary and proper, however ... health care reform will bring to all Americans.   We must ...
... , Jan. 25 January is almost over and ... spirit of the Holidays, the Phoenix Quest Center is offering the ... development.  This course is a great opportunity to help participants start ... as offering them valuable skills in dealing with social conflicts of ...
... , PHILADELPHIA , Jan. 25 ... defects in humans, affecting 8 per 1000 live births ... early infancy. Increasing numbers of survivors combined with developmental ... led to a growing identification of neurobehavioral symptoms in ...
Cached Medicine News:Health News:Preoperative CT useful for younger women with suspected appendicitis 2Health News:Physical Therapist Pleads Guilty in Connection with Detroit Home Health Care Fraud Scheme 2Health News:Physical Therapist Pleads Guilty in Connection with Detroit Home Health Care Fraud Scheme 3Health News:Scott Roeder Trial: Randall Terry, Operation Rescue Founder and Insurrecta Nex Members to Attend Trial in Wichita 2Health News:National Medical Association Urges Congress to Deliver on Health Care 2Health News:60-Day Free Community Confidence Building and Self-Defense Training 2Health News:Special Bypass Procedure Used During Infant Heart Surgery Does Not Impair Later Neurological Outcomes in Children 2Health News:Special Bypass Procedure Used During Infant Heart Surgery Does Not Impair Later Neurological Outcomes in Children 3
... Split Splint reduces PIP joint or DIP joint ... to put on. Soft gel-lining cushions injured fingers ... begin earlier for faster, more successful therapy results. ... and at night to maintain gains in motion. ...
... restore full PIP joint or DIP joint ... to arthritic changes. Unparalleled in comfort and ... finger to prevent slipping and allows for ... Sold in packages of 5 and boxes ...
One splint does it all....
... of minor knee pain like arthritis, tendonitis ... with the motion of the knee, applying ... tendon and assisting in the relief of ... with high density foam padding molds itself ...
Medicine Products: